LXRX
Lexicon Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
6.59 / 10
Outperform
The fund flow profile scores 7.8/10, reflecting robust inflows; Small and Extra-large flows show positive trends, though overall block and Medium flows are negative. Analyst consensus is overwhelmingly bullish with a Strong Buy rating from HC Wainwright & Co., but the current price trend is falling (-21.66%), creating a mismatch between expectations and price action. This divergence should be monitored for potential reversals.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-09-02
InstitutionHC Wainwright & Co.
Times predicted5
Historical Win Rate60.0%
Is money flowing into or out of LXRX?
- LXRX holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.59/10 (Outperform).
